Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The expression and prognosis of Emi1 and Skp2 in breast carcinoma: associated with PI3K/Akt pathway and cell proliferation.

Liu X, Wang H, Ma J, Xu J, Sheng C, Yang S, Sun L, Ni Q.

Med Oncol. 2013 Dec;30(4):735. doi: 10.1007/s12032-013-0735-0. Epub 2013 Oct 25.

PMID:
24277465
2.

Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).

Zhao Y, Tang Q, Ni R, Huang X, Wang Y, Lu C, Shen A, Wang Y, Li C, Yuan Q, Chen H, Cheng C, He S.

Hum Pathol. 2013 Mar;44(3):365-73. doi: 10.1016/j.humpath.2012.03.030. Epub 2012 Sep 17.

PMID:
22995332
3.

Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: correlation with Jab1 stability and PI3K/Akt pathway.

Wang H, Liu XB, Chen JH, Wang QQ, Chen JP, Xu JF, Sheng CY, Ni QC.

Exp Mol Pathol. 2014 Oct;97(2):191-201. doi: 10.1016/j.yexmp.2014.07.012. Epub 2014 Jul 16.

PMID:
25036402
4.

Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.

Liu J, Wei XL, Huang WH, Chen CF, Bai JW, Zhang GJ.

PLoS One. 2012;7(12):e52675. doi: 10.1371/journal.pone.0052675. Epub 2012 Dec 27. Erratum in: PLoS One. 2013;8(7). doi:10.1371/annotation/d8502df1-611d-4d4a-b697-acaee15ac8c8.

5.
6.
7.
8.

COX-2 correlates with F-box protein, Skp2 expression and prognosis in human gastric carcinoma.

Honjo S, Kase S, Osaki M, Ardyanto TD, Kaibara N, Ito H.

Int J Oncol. 2005 Feb;26(2):353-60.

PMID:
15645119
9.

Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer.

Radke S, Pirkmaier A, Germain D.

Oncogene. 2005 May 12;24(21):3448-58.

PMID:
15782142
10.

[Rosiglitazone inhibits human HepG2 cell proliferation via PI3K/PTEN/Akt signaling pathway].

Zhang M, Peng L, Qiao Z, He H, Zhou Y, Xu Z.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Feb;30(2):147-50. Chinese.

PMID:
24491054
12.

Significance of skp2 expression in primary breast cancer.

Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda TA, Mori M.

Clin Cancer Res. 2006 Feb 15;12(4):1215-20.

13.
14.
15.

Epidermal growth factor upregulates Skp2/Cks1 and p27(kip1) in human extrahepatic cholangiocarcinoma cells.

Kim JY, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI, Kim DH, Chae SW, Sohn JH.

World J Gastroenterol. 2014 Jan 21;20(3):755-73. doi: 10.3748/wjg.v20.i3.755.

16.
17.

Differential effects of doxorubicin treatment on cell cycle arrest and Skp2 expression in breast cancer cells.

Bar-On O, Shapira M, Hershko DD.

Anticancer Drugs. 2007 Nov;18(10):1113-21.

PMID:
17893511
18.

Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.

Motti ML, Califano D, Troncone G, De Marco C, Migliaccio I, Palmieri E, Pezzullo L, Palombini L, Fusco A, Viglietto G.

Am J Pathol. 2005 Mar;166(3):737-49.

19.

Clear cell carcinomas of the ovary: a multi-institutional study of 129 cases in Korea with prognostic significance of Emi1 and Galectin-3.

Min KW, Park MH, Hong SR, Lee H, Kwon SY, Hong SH, Joo HJ, Park IA, An HJ, Suh KS, Oh HK, Yoo CW, Kim MJ, Chang HK, Jun SY, Yoon HK, Chang ED, Kim DW, Kim I; Gynecologic Pathology Study Group of the Korean Society of Pathologists.

Int J Gynecol Pathol. 2013 Jan;32(1):3-14. doi: 10.1097/PGP.0b013e31825554e9.

PMID:
23202783
20.

[Expression and clinicopathological significance of Emi1 in breast carcinoma].

Liu X, Ni Q, Sheng C, Ma J, Wang Q.

Zhonghua Yi Xue Za Zhi. 2014 Jul 8;94(26):2008-12. Chinese.

PMID:
25312659

Supplemental Content

Support Center